Literature DB >> 11514229

Structural requirements for the biosynthesis of backbone cyclic peptide libraries.

C P Scott1, E Abel-Santos, A D Jones, S J Benkovic.   

Abstract

BACKGROUND: Combinatorial methods for the production of molecular libraries are an important source of ligand diversity for chemical biology. Synthetic methods focus on the production of small molecules that must traverse the cell membrane to elicit a response. Genetic methods enable intracellular ligand production, but products must typically be large molecules in order to withstand cellular catabolism. Here we describe an intein-based approach to biosynthesis of backbone cyclic peptide libraries that combines the strengths of synthetic and genetic methods.
RESULTS: Through site-directed mutagenesis we show that the DnaE intein from Synechocystis sp. PCC6803 is very promiscuous with respect to peptide substrate composition, and can generate cyclic products ranging from four to nine amino acids. Libraries with five variable amino acids and either one or four fixed residues were prepared, yielding between 10(7) and 10(8) transformants. The majority of randomly selected clones from each library gave cyclic products.
CONCLUSIONS: We have developed a versatile method for producing intracellular libraries of small, stable cyclic peptides. Genetic encoding enables facile manipulation of vast numbers of compounds, while low molecular weight ensures ready pharmacophore identification. The demonstrated flexibility of the method towards both peptide length and composition makes it a valuable addition to existing methods for generating ligand diversity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514229     DOI: 10.1016/s1074-5521(01)00052-7

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  18 in total

1.  Taking the chemical out of chemical genetics.

Authors:  Charles P Scott
Journal:  Nat Chem Biol       Date:  2009-09       Impact factor: 15.040

2.  Using siclopps for the discovery of novel antimicrobial peptides and their targets.

Authors:  Lisa O Nilsson; Mostafa Louassini; Ernesto Abel-Santos
Journal:  Protein Pept Lett       Date:  2005-11       Impact factor: 1.890

3.  Ribosomal Synthesis of Natural-Product-Like Bicyclic Peptides in Escherichia coli.

Authors:  Nina Bionda; Rudi Fasan
Journal:  Chembiochem       Date:  2015-08-06       Impact factor: 3.164

Review 4.  Various mechanisms in cyclopeptide production from precursors synthesized independently of non-ribosomal peptide synthetases.

Authors:  Wenyan Xu; Liling Li; Liangcheng Du; Ninghua Tan
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2011-07-14       Impact factor: 3.848

5.  A promiscuous split intein with expanded protein engineering applications.

Authors:  Adam J Stevens; Giridhar Sekar; Neel H Shah; Anahita Z Mostafavi; David Cowburn; Tom W Muir
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

Review 6.  Biological activities of natural and engineered cyclotides, a novel molecular scaffold for peptide-based therapeutics.

Authors:  Angie E Garcia; Julio A Camarero
Journal:  Curr Mol Pharmacol       Date:  2010-11       Impact factor: 3.339

7.  Rapid selection of cyclic peptides that reduce alpha-synuclein toxicity in yeast and animal models.

Authors:  Joshua A Kritzer; Shusei Hamamichi; J Michael McCaffery; Sandro Santagata; Todd A Naumann; Kim A Caldwell; Guy A Caldwell; Susan Lindquist
Journal:  Nat Chem Biol       Date:  2009-07-13       Impact factor: 15.040

Review 8.  "Splicing up" drug discovery. Cell-based expression and screening of genetically-encoded libraries of backbone-cyclized polypeptides.

Authors:  Harshkumar Sancheti; Julio A Camarero
Journal:  Adv Drug Deliv Rev       Date:  2009-07-21       Impact factor: 15.470

9.  Chemical and biological production of cyclotides.

Authors:  Yilong Li; Tao Bi; Julio A Camarero
Journal:  Adv Bot Res       Date:  2015       Impact factor: 2.175

Review 10.  Recombinant expression of backbone-cyclized polypeptides.

Authors:  Radhika Borra; Julio A Camarero
Journal:  Biopolymers       Date:  2013-09       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.